View Post

First Monoclonal Antibody to Treat COVID-19 Approved

In COVID-19, Latest News by Precision Vaccinations

The first monoclonal antibody (mAbs) to treat COVID-19 has joined a short list of U.S. Food and Drug Administration (FDA) approved antivirals.
Roche announced yesterday that the FDA had approved Actemra® (tocilizumab) intravenous (IV) for the treatment of COVID-19 in hospitalized adult patients receiving systemic corticosteroids and requiring supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation.

View Post

First Approved Capsid Inhibitor-Based HIV Treatment Option

In COVID-19, Latest News by Precision Vaccinations

While the U.S. Food and Drug Administration (FDA) has yet to approve an HIV vaccine candidate, approvals have been granted for the treatment of HIV-1 infection in heavily treatment-experienced (HTE) adults with multi-drug resistant (MDR) HIV-1 infection.
Gilead Sciences, Inc. announced today that Sunlenca® (lenacapavir), in combination with other antiretrovirals, has been granted approval by the U.S. FDA for treating HIV-1 infection in HTE adults with MDR HIV-1 infection.
Sunlenca is now the first and only FDA Approved Capsid Inhibitor-Based HIV treatment option.